How the IRA shifted the drug pricing debate

One year after President Biden signed the Inflation Reduction Act, the future of the law's signature drug pricing policy — Medicare negotiations — is up in the air. Why it matters: A barrage of lawsuits from drugmakers and allied groups are seeking to overturn provisions enabling Medicare to negotiate drug prices, just as the Biden administration is preparing to announce the…